Improving Anticancer Therapy with Naringenin-Loaded Silk Fibroin Nanoparticles

Naringenin (NAR), a flavonoid present in a variety of fruits, vegetables and herbs, exhibits a wide range of pharmacological effects, including anticancer activity. Nevertheless, its application in cancer therapy is limited due to its low bioavailability at the tumour site because of its poor solubi...

Full description

Bibliographic Details
Main Authors: Marta G. Fuster, Guzmán Carissimi, Mercedes G. Montalbán, Gloria Víllora
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Nanomaterials
Subjects:
Online Access:https://www.mdpi.com/2079-4991/10/4/718
_version_ 1797570997171257344
author Marta G. Fuster
Guzmán Carissimi
Mercedes G. Montalbán
Gloria Víllora
author_facet Marta G. Fuster
Guzmán Carissimi
Mercedes G. Montalbán
Gloria Víllora
author_sort Marta G. Fuster
collection DOAJ
description Naringenin (NAR), a flavonoid present in a variety of fruits, vegetables and herbs, exhibits a wide range of pharmacological effects, including anticancer activity. Nevertheless, its application in cancer therapy is limited due to its low bioavailability at the tumour site because of its poor solubility in water and slow dissolution rate. To improve the therapeutic efficacy of NAR, emergent research is looking into using nanocarriers. Silk fibroin (SF), from the <i>Bombyx mori</i> silkworm, is a biocompatible and biodegradable polymer with excellent mechanical properties and an amphiphilic chemistry that make it a promising candidate as a controlled release drug system. The aim of this work is to synthesize naringenin-loaded silk fibroin nanoparticles (NAR-SFNs) by dissolving the SF in the ionic liquid 1-ethyl-3-methylimidazolium acetate, using high-power ultrasounds and rapid desolvation in methanol followed by the adsorption of NAR. The NAR-SFNs were characterized by dynamic light scattering, Fourier transform infrared spectroscopy and thermogravimetric analysis. The drug loading content and encapsulation efficiency were calculated. The drug release profile best fitted a first order equation. The cytotoxicity effects of free NAR, bare silk fibroin nanoparticles (SFNs) and NAR-SFNs were assessed on HeLa and EA.hy926 cells via 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The results demonstrated the higher in vitro anticancer potential of synthesized NAR-SFNs than that of free NAR in HeLa cancer cells.
first_indexed 2024-03-10T20:33:20Z
format Article
id doaj.art-c7758fea944f4e629d50ab95638294ae
institution Directory Open Access Journal
issn 2079-4991
language English
last_indexed 2024-03-10T20:33:20Z
publishDate 2020-04-01
publisher MDPI AG
record_format Article
series Nanomaterials
spelling doaj.art-c7758fea944f4e629d50ab95638294ae2023-11-19T21:14:46ZengMDPI AGNanomaterials2079-49912020-04-0110471810.3390/nano10040718Improving Anticancer Therapy with Naringenin-Loaded Silk Fibroin NanoparticlesMarta G. Fuster0Guzmán Carissimi1Mercedes G. Montalbán2Gloria Víllora3Department of Chemical Engineering, Faculty of Chemistry, University of Murcia (UMU), Campus de Espinardo, 30100 Murcia, SpainDepartment of Chemical Engineering, Faculty of Chemistry, University of Murcia (UMU), Campus de Espinardo, 30100 Murcia, SpainDepartment of Chemical Engineering, Faculty of Chemistry, University of Murcia (UMU), Campus de Espinardo, 30100 Murcia, SpainDepartment of Chemical Engineering, Faculty of Chemistry, University of Murcia (UMU), Campus de Espinardo, 30100 Murcia, SpainNaringenin (NAR), a flavonoid present in a variety of fruits, vegetables and herbs, exhibits a wide range of pharmacological effects, including anticancer activity. Nevertheless, its application in cancer therapy is limited due to its low bioavailability at the tumour site because of its poor solubility in water and slow dissolution rate. To improve the therapeutic efficacy of NAR, emergent research is looking into using nanocarriers. Silk fibroin (SF), from the <i>Bombyx mori</i> silkworm, is a biocompatible and biodegradable polymer with excellent mechanical properties and an amphiphilic chemistry that make it a promising candidate as a controlled release drug system. The aim of this work is to synthesize naringenin-loaded silk fibroin nanoparticles (NAR-SFNs) by dissolving the SF in the ionic liquid 1-ethyl-3-methylimidazolium acetate, using high-power ultrasounds and rapid desolvation in methanol followed by the adsorption of NAR. The NAR-SFNs were characterized by dynamic light scattering, Fourier transform infrared spectroscopy and thermogravimetric analysis. The drug loading content and encapsulation efficiency were calculated. The drug release profile best fitted a first order equation. The cytotoxicity effects of free NAR, bare silk fibroin nanoparticles (SFNs) and NAR-SFNs were assessed on HeLa and EA.hy926 cells via 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The results demonstrated the higher in vitro anticancer potential of synthesized NAR-SFNs than that of free NAR in HeLa cancer cells.https://www.mdpi.com/2079-4991/10/4/718anticancer activitynaringeninsilk fibroinnanoparticlegreen synthesisionic liquids
spellingShingle Marta G. Fuster
Guzmán Carissimi
Mercedes G. Montalbán
Gloria Víllora
Improving Anticancer Therapy with Naringenin-Loaded Silk Fibroin Nanoparticles
Nanomaterials
anticancer activity
naringenin
silk fibroin
nanoparticle
green synthesis
ionic liquids
title Improving Anticancer Therapy with Naringenin-Loaded Silk Fibroin Nanoparticles
title_full Improving Anticancer Therapy with Naringenin-Loaded Silk Fibroin Nanoparticles
title_fullStr Improving Anticancer Therapy with Naringenin-Loaded Silk Fibroin Nanoparticles
title_full_unstemmed Improving Anticancer Therapy with Naringenin-Loaded Silk Fibroin Nanoparticles
title_short Improving Anticancer Therapy with Naringenin-Loaded Silk Fibroin Nanoparticles
title_sort improving anticancer therapy with naringenin loaded silk fibroin nanoparticles
topic anticancer activity
naringenin
silk fibroin
nanoparticle
green synthesis
ionic liquids
url https://www.mdpi.com/2079-4991/10/4/718
work_keys_str_mv AT martagfuster improvinganticancertherapywithnaringeninloadedsilkfibroinnanoparticles
AT guzmancarissimi improvinganticancertherapywithnaringeninloadedsilkfibroinnanoparticles
AT mercedesgmontalban improvinganticancertherapywithnaringeninloadedsilkfibroinnanoparticles
AT gloriavillora improvinganticancertherapywithnaringeninloadedsilkfibroinnanoparticles